296 related articles for article (PubMed ID: 10661498)
1. Prevention of precipitated withdrawal symptoms by activating central cholinergic systems during a dependence-producing schedule of morphine in rats.
Buccafusco JJ; Zhang LC; Shuster LC; Jonnala RR; Gattu M
Brain Res; 2000 Jan; 852(1):76-83. PubMed ID: 10661498
[TBL] [Abstract][Full Text] [Related]
2. Prevention of morphine-induced muscarinic (M2) receptor adaptation suppresses the expression of withdrawal symptoms.
Zhang LC; Buccafusco JJ
Brain Res; 1998 Aug; 803(1-2):114-21. PubMed ID: 9729319
[TBL] [Abstract][Full Text] [Related]
3. Spinal NMDA receptor--nitric oxide mediation of the expression of morphine withdrawal symptoms in the rat.
Buccafusco JJ; Terry AV; Shuster L
Brain Res; 1995 May; 679(2):189-99. PubMed ID: 7633880
[TBL] [Abstract][Full Text] [Related]
4. Cardiovascular and behavioural effects induced by naloxone-precipitated morphine withdrawal in rat: characterization with tachykinin antagonists.
Michaud N; Couture R
Neuropeptides; 2003 Dec; 37(6):345-54. PubMed ID: 14698677
[TBL] [Abstract][Full Text] [Related]
5. A 24-h access I.V. self-administration schedule of morphine reinforcement and the estimation of recidivism: Pharmacological modification by arecoline.
Buccafusco JJ; Bain JN
Neuroscience; 2007 Nov; 149(3):487-98. PubMed ID: 17916413
[TBL] [Abstract][Full Text] [Related]
6. Role of spinal and supraspinal muscarinic receptors in the expression of morphine withdrawal symptoms in the rat.
Holland LN; Shuster LC; Buccafusco JJ
Neuropharmacology; 1993 Dec; 32(12):1387-95. PubMed ID: 8152529
[TBL] [Abstract][Full Text] [Related]
7. The role of afferent inputs to supraoptic nucleus oxytocin neurons during naloxone-precipitated morphine withdrawal in the rat.
Murphy NP; Onaka T; Brown CH; Leng G
Neuroscience; 1997 Sep; 80(2):567-77. PubMed ID: 9284358
[TBL] [Abstract][Full Text] [Related]
8. Naloxone-precipitated withdrawal jumping in 11 inbred mouse strains: evidence for common genetic mechanisms in acute and chronic morphine physical dependence.
Kest B; Palmese CA; Hopkins E; Adler M; Juni A; Mogil JS
Neuroscience; 2002; 115(2):463-9. PubMed ID: 12421612
[TBL] [Abstract][Full Text] [Related]
9. Opiate withdrawal signs precipitated by naloxone following a single exposure to morphine: potentiation with a second morphine exposure.
Schulteis G; Heyser CJ; Koob GF
Psychopharmacology (Berl); 1997 Jan; 129(1):56-65. PubMed ID: 9122364
[TBL] [Abstract][Full Text] [Related]
10. The role of nitric oxide in morphine dependence and withdrawal excitation of rat oxytocin neurons.
Bull PM; Ludwig M; Blackburn-Munro GJ; Delgado-Cohen H; Brown CH; Russell JA
Eur J Neurosci; 2003 Nov; 18(9):2545-51. PubMed ID: 14622155
[TBL] [Abstract][Full Text] [Related]
11. Conditioning processes contribute to severity of naloxone-precipitated withdrawal from acute opioid dependence.
Schulteis G; Morse AC; Liu J
Psychopharmacology (Berl); 2004 Oct; 175(4):463-72. PubMed ID: 15083263
[TBL] [Abstract][Full Text] [Related]
12. [Effect of melatonin on mean blood pressure and heart rate in morphine withdrawal rats].
He W; Zhu X; Wang H; Qiu Y; Qiu X
Yao Xue Xue Bao; 1998 Oct; 33(10):727-30. PubMed ID: 12016923
[TBL] [Abstract][Full Text] [Related]
13. Differential expression of response-disruptive and somatic indices of opiate withdrawal during the initiation and development of opiate dependence.
Schulteis G; Heyser CJ; Koob GF
Behav Pharmacol; 1999 May; 10(3):235-42. PubMed ID: 10780239
[TBL] [Abstract][Full Text] [Related]
14. Naloxone rapidly evokes endogenous kappa opioid receptor-mediated hyperalgesia in naïve mice pretreated briefly with GM1 ganglioside or in chronic morphine-dependent mice.
Crain SM; Shen KF
Brain Res; 2007 Sep; 1167():31-41. PubMed ID: 17692296
[TBL] [Abstract][Full Text] [Related]
15. Spinal cholinergic neurons and the expression of morphine withdrawal symptoms in the rat.
Marshall DC; Buccafusco JJ
J Neurosci; 1987 Mar; 7(3):621-8. PubMed ID: 3559705
[TBL] [Abstract][Full Text] [Related]
16. The role of cholinergic systems in the expression of morphine withdrawal.
Sharif SI; el-Kadi AO
Neurosci Res; 1996 Jun; 25(2):155-60. PubMed ID: 8829152
[TBL] [Abstract][Full Text] [Related]
17. [Activation of the spinal extracellular signal-regulated kinase is involved in morphine dependence and naloxone-precipitated withdrawal response].
He JH; Cao JL; Xu YB; Song XS; Ding HL; Zeng YM
Sheng Li Xue Bao; 2005 Oct; 57(5):557-65. PubMed ID: 16220193
[TBL] [Abstract][Full Text] [Related]
18. Gender differences in the cardiovascular responses to morphine and naloxone in spinal rats.
Cruz SL; Rodríguez-Manzo G
Eur J Pharmacol; 2000 May; 397(1):121-8. PubMed ID: 10844106
[TBL] [Abstract][Full Text] [Related]
19. Effect of agmatine on the development of morphine dependence in rats: potential role of cAMP system.
Aricioglu F; Means A; Regunathan S
Eur J Pharmacol; 2004 Nov; 504(3):191-7. PubMed ID: 15541421
[TBL] [Abstract][Full Text] [Related]
20. [Different roles of the spinal protein kinase C alpha and gamma in morphine dependence and naloxone-precipitated withdrawal].
Cao JL; Ding HL; He JH; Zhang LC; Wang JK; Zeng YM
Sheng Li Xue Bao; 2005 Apr; 57(2):161-8. PubMed ID: 15830100
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
